0.84% 0.14

Acadia Pharmaceuticals Inc (ACAD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ACAD Giù? Forum Previsione

Acadia Pharmaceuticals Inc Azioni (ACAD) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	10.91% 205.83	231.04	211.70	165.24	118.46
Cost Of Revenue	28.29% 22.95	17.89	14.62	7.459	1.667
Gross Profit	14.20% 182.88	213.15	197.08	157.78	116.80
Operating Expenses	5.91% 167.67	178.21	254.85	154.74	170.38
Benefits Costs and Expenses	184.83	-	-	-	-
Costs And Expenses	190.62	-	269.48	162.20	172.05
Operating Income/Loss	56.47% 15.21	34.94	-57.78	3.037	-53.58
Income/Loss From Continuing Operations Before Tax	90.91% 21.00	231.04	-52.14	6.343	-44.94
Income Tax Expense/Benefit	172.97% 4.447	-6.094	13.03	5.229	-1.918
Income/Loss From Continuing Operations After Tax	63.85% 16.55	45.80	-65.18	1.114	-43.02
Net Income/Loss	63.85% 16.55	45.80	-65.18	1.114	-43.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	49.79M% 164.80	0.000331	0.1642	0.1635	162.26
Diluted Average Shares	50.34M% 166.62	0.000331	0.1642	0.165	162.26
Basic Earnings Per Share	64.29% 0.10	0.28	-0.40	0.01	-0.27
Diluted Earnings Per Share	64.29% 0.10	0.28	-0.40	0.01	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%